circUSP34 accelerates osteosarcoma malignant progression by sponging miR-16-5p

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma (OS) is a highly malignant bone tumor with unclear pathological mechanisms.
• Circular RNAs (circRNAs) are implicated in various cancers, but their role in OS requires further elucidation.
• MicroRNAs (miRNAs) like miR-16-5p have shown inhibitory effects on OS progression.

Purpose of the Study:

• To investigate the sponging mechanism between circRNAs and miRNAs in osteosarcoma.
• To determine the role of circUSP34 as a potential sponge for miR-16-5p in OS.
• To evaluate the therapeutic potential of targeting the circUSP34/miR-16-5p axis in OS.

Main Methods:

• Bioinformatic analysis (Starbase) to identify potential circRNA-miRNA interactions.
• Quantitative real-time PCR (qRT-PCR) to assess circUSP34 and miR-16-5p expression levels.
• In vitro and in vivo functional assays (proliferation, migration, invasion, xenograft mouse models) to evaluate circUSP34's role.
• Molecular biology techniques including Western blotting, FISH, dual-luciferase reporter assay, RNA immunoprecipitation (RIP), and RNA pull-down assays to confirm the sponging mechanism.

Main Results:

• circUSP34 expression was upregulated, while miR-16-5p was downregulated in OS tissues.
• circUSP34 significantly promoted OS cell proliferation, migration, and invasion in vitro and in vivo.
• Knocking out circUSP34 or mimicking miR-16-5p inhibited OS cell malignancy, decreasing vimentin and Ki-67 expression.
• circUSP34 directly sponged miR-16-5p, verified by multiple molecular assays.
• Inhibition of miR-16-5p partially reversed the anti-tumor effects of circUSP34 knockdown.

Conclusions:

• circUSP34 acts as a molecular sponge for miR-16-5p, promoting osteosarcoma progression.
• The circUSP34/miR-16-5p axis represents a novel regulatory pathway in OS.
• circUSP34 holds potential as a diagnostic biomarker and therapeutic target for osteosarcoma.